Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review.
Amira SalimElise HennessyClaire SonnebornOlivia HogueSudipa BiswasMaryAnn MaysAarushi SunejaZubair AhmedIgnacio Fernandez MataPublished in: CNS drugs (2024)
Dual therapy of anti-CGRP mAbs and onabot may be more efficacious than monotherapy, possibly due to their synergistic mechanisms of action.